CERE Annual CFI
$73.72 M
+$462.56 M+118.96%
31 December 2023
Summary:
As of January 29, 2025, CERE annual cash flow from investing activities is $73.72 million, with the most recent change of +$462.56 million (+118.96%) on December 31, 2023. During the last 3 years, it has risen by +$92.61 million (+490.23%).CERE Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CERE Quarterly CFI
$19.16 M
+$169.37 M+112.76%
31 March 2024
Summary:
As of January 29, 2025, CERE quarterly cash flow from investing activities is $19.16 million, with the most recent change of +$169.37 million (+112.76%) on March 31, 2024. Over the past year, it has dropped by -$32.23 million (-62.71%).CERE Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CERE TTM CFI
-$17.90 M
-$91.62 M-124.27%
31 March 2024
Summary:
As of January 29, 2025, CERE TTM cash flow from investing activities is -$17.90 million, with the most recent change of -$91.62 million (-124.27%) on March 31, 2024. Over the past year, it has dropped by -$215.09 million (-109.08%).CERE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CERE Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +119.0% | -62.7% | -109.1% |
| 3 y3 years | +490.2% | +149.7% | +96.2% |
| 5 y5 years | +6808.1% | +149.7% | +96.2% |
CERE Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -82.7% | -109.1% |
Cerevel Therapeutics Holdings Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $19.16 M(-112.8%) | -$17.90 M(-124.3%) |
| Dec 2023 | $73.72 M(-119.0%) | -$150.21 M(-392.3%) | $73.72 M(-62.6%) |
| Sept 2023 | - | $51.39 M(-16.8%) | $197.20 M(-181.5%) |
| June 2023 | - | $61.75 M(-44.3%) | -$242.05 M(+1.1%) |
| Mar 2023 | - | $110.78 M(-514.4%) | -$239.51 M(-38.4%) |
| Dec 2022 | -$388.83 M(-10.7%) | -$26.73 M(-93.1%) | -$388.83 M(-50.7%) |
| Sept 2022 | - | -$387.85 M(-703.3%) | -$788.33 M(+96.3%) |
| June 2022 | - | $64.29 M(-266.8%) | -$401.67 M(-14.5%) |
| Mar 2022 | - | -$38.54 M(-91.0%) | -$469.54 M(+7.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$435.66 M(+2206.1%) | -$426.23 M(>+9900.0%) | -$435.66 M(+2465.4%) |
| Sept 2021 | - | -$1.19 M(-66.8%) | -$16.98 M(-26.5%) |
| June 2021 | - | -$3.58 M(-23.1%) | -$23.09 M(+10.0%) |
| Mar 2021 | - | -$4.66 M(-38.3%) | -$21.00 M(+11.1%) |
| Dec 2020 | -$18.89 M(+1619.0%) | -$7.55 M(+3.5%) | -$18.89 M(+66.6%) |
| Sept 2020 | - | -$7.30 M(+391.2%) | -$11.34 M(+180.6%) |
| June 2020 | - | -$1.49 M(-41.9%) | -$4.04 M(+58.1%) |
| Mar 2020 | - | -$2.56 M | -$2.56 M |
| Dec 2019 | -$1.10 M | - | - |
FAQ
- What is Cerevel Therapeutics Holdings annual cash flow from investing activities?
- What is the all time high annual CFI for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings annual CFI year-on-year change?
- What is Cerevel Therapeutics Holdings quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings quarterly CFI year-on-year change?
- What is Cerevel Therapeutics Holdings TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings TTM CFI year-on-year change?
What is Cerevel Therapeutics Holdings annual cash flow from investing activities?
The current annual CFI of CERE is $73.72 M
What is the all time high annual CFI for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high annual cash flow from investing activities is $73.72 M
What is Cerevel Therapeutics Holdings annual CFI year-on-year change?
Over the past year, CERE annual cash flow from investing activities has changed by +$462.56 M (+118.96%)
What is Cerevel Therapeutics Holdings quarterly cash flow from investing activities?
The current quarterly CFI of CERE is $19.16 M
What is the all time high quarterly CFI for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high quarterly cash flow from investing activities is $110.78 M
What is Cerevel Therapeutics Holdings quarterly CFI year-on-year change?
Over the past year, CERE quarterly cash flow from investing activities has changed by -$32.23 M (-62.71%)
What is Cerevel Therapeutics Holdings TTM cash flow from investing activities?
The current TTM CFI of CERE is -$17.90 M
What is the all time high TTM CFI for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high TTM cash flow from investing activities is $197.20 M
What is Cerevel Therapeutics Holdings TTM CFI year-on-year change?
Over the past year, CERE TTM cash flow from investing activities has changed by -$215.09 M (-109.08%)